• Please log in or register to access this feature.

Empirical Article (CE Activity)

You have free access to this content

A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder

  1. Susan L. McElroy MD1,2,*,
  2. Anna I. Guerdjikova PhD, LISW1,2,
  3. Thomas J. Blom MS2,
  4. Scott J. Crow MD3,
  5. Asli Memisoglu PhD4,
  6. Bernard L. Silverman MD4,
  7. Elliot W. Ehrich MD4

Article first published online: 5 FEB 2013

DOI: 10.1002/eat.22114

Issue

International Journal of Eating Disorders

International Journal of Eating Disorders

Volume 46, Issue 3, pages 239–245, April 2013

Additional Information

How to Cite

McElroy, S. L., Guerdjikova, A. I., Blom, T. J., Crow, S. J., Memisoglu, A., Silverman, B. L. and Ehrich, E. W. (2013), A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder. Int. J. Eat. Disord., 46: 239–245. doi: 10.1002/eat.22114

Author Information

  1. 1

    Lindner Center of HOPE, Research Institute, Mason, Ohio

  2. 2

    Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio

  3. 3

    Department of Psychiatry, University of Minnesota Medical School, Minneapolis, Minnesota

  4. 4

    Alkermes Inc., Cambridge, Massachusetts

*MD, Lindner Center of HOPE, Research Institute, 4075 Old Western Row Road, Mason, OH

Publication History

  1. Issue published online: 11 MAR 2013
  2. Article first published online: 5 FEB 2013
  3. Manuscript Revised: 25 DEC 2012

Funded by

  • Alkermes. Grant Number: NCT01098435

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS